Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

709 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report.
Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, van Den Brink W. Reneman L, et al. Among authors: van den brink w, den heeten gj. Psychopharmacology (Berl). 2002 Jan;159(3):335-40. doi: 10.1007/s00213-001-0930-0. Epub 2001 Nov 20. Psychopharmacology (Berl). 2002. PMID: 11862367
Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W. Rinne T, et al. Among authors: van den brink w. Biol Psychiatry. 2002 Dec 1;52(11):1102-12. doi: 10.1016/s0006-3223(02)01395-1. Biol Psychiatry. 2002. PMID: 12460693 Clinical Trial.
Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
de Win MM, Habraken JB, Reneman L, van den Brink W, den Heeten GJ, Booij J. de Win MM, et al. Among authors: van den brink w, den heeten gj. Neuropsychopharmacology. 2005 May;30(5):996-1005. doi: 10.1038/sj.npp.1300683. Neuropsychopharmacology. 2005. PMID: 15770240 Clinical Trial.
The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.
De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W. De Win MM, et al. Among authors: van den brink w, den heeten gj. Int J Methods Psychiatr Res. 2005;14(4):167-85. doi: 10.1002/mpr.6. Int J Methods Psychiatr Res. 2005. PMID: 16395871 Free PMC article.
709 results